SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Thuresson Marcus)
 

Sökning: WFRF:(Thuresson Marcus) > Gastrointestinal ca...

  • Vujasinovic, MiroslavDepartment of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska institutet, Stockholm, Sweden (författare)

Gastrointestinal cancer precursor risk and mortality in pancreatic intraductal papillary mucinous neoplasms : a nationwide cohort study

  • Artikel/kapitelEngelska2024

Förlag, utgivningsår, omfång ...

  • Taylor & Francis,2024
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-111908
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-111908URI
  • https://doi.org/10.1080/00365521.2024.2310162DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:154938866URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background and aims: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is a precursor of pancreatic cancer. While earlier research has shown a high prevalence of synchronous/metachronous extrapancreatic tumors in IPMN patients, these studies have often been small with retrospective data collection. The aim of the study was to examine absolute and relative risks of non-pancreatic gastrointestinal (GI) cancer precursors and mortality in histologically confirmed IPMN.Methods: Through the nationwide ESPRESSO histopathology cohort, we retrieved data on IPMN between 1965 and 2016. Each index case was matched to <= 5 general population controls. Through Cox regression, we estimated hazard ratios (HRs) for future GI cancer precursors and death.Results: A total of 117 patients with IPMN and 539 age- and sex-matched controls were included. Over a median of 2.1 years of follow up, we confirmed two (1.7%) incident GI cancer precursors in IPMN vs. four (0.7%) in controls, corresponding to an HR of 1.89 (95%CI = 0.34-10.55). By contrast, IPMN patients were at increased risk of death (HR 3.61 (95%CI = 1.79-7.27)). The most common cause of death in IPMN was pancreatic cancer (n = 14; 45.2% of all deaths).Conclusions: We found no association between IPMN and other GI cancer precursors. This argues against comprehensive routine surveillance for other GI cancer precursors in IPMN patients. Mortality was increased in IPMN with pancreatic cancer being the most common cause of death, indicating the need for lifelong follow up in all resected and non-resected patients with IPMN. However, results should be confirmed in larger cohorts.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Elbe, PeterDepartment of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden (författare)
  • Ekheden, IsabellaDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, weden (författare)
  • Wang, Qiao-LiDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston MA, USA (författare)
  • Thuresson, MarcusStatisticon AB, Uppsala, Sweden (författare)
  • Roelstraete, BjornDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (författare)
  • Ghazi, SamDepartment of Pathology, Karolinska University Hospital, Stockholm, Sweden (författare)
  • Löhr, J. -MatthiasDepartment of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden (författare)
  • Ludvigsson, Jonas F.,1969-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Celiac Disease Center, Department of Medicine, Columbia University Medical Center, NY, USA; Department of Pediatrics, Örebro University Hospital, Örebro University, Örebro, Sweden(Swepub:oru)jsln (författare)
  • Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska institutet, Stockholm, SwedenDepartment of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Scandinavian Journal of Gastroenterology: Taylor & Francis0036-55211502-7708

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy